Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,345.00p
   
  • Change Today:
    -6.00p
  • 52 Week High: 1,530.00
  • 52 Week Low: 1,016.00
  • Currency: UK Pounds
  • Shares Issued: 216.17m
  • Volume: 156,141
  • Market Cap: £2,907.53m
  • RiskGrade: 169

Regulatory News

Total Voting Rights 02-Jul-2020 10:11 RNS
Directorate Change 16-Jun-2020 12:00 RNS
Total Voting Rights 01-Jun-2020 09:29 RNS
Statement re Update on 2019 AGM Resolution Vote 11-May-2020 11:00 RNS
Total Voting Rights 01-May-2020 12:24 RNS
Holding(s) in Company 22-Apr-2020 10:11 RNS
Director/PDMR Shareholding 21-Apr-2020 07:26 RNS
Holding(s) in Company 20-Apr-2020 10:19 RNS
COVID-19 Update 20-Apr-2020 07:00 RNS
Holding(s) in Company 14-Apr-2020 10:07 RNS
Issue of Shares 09-Apr-2020 17:33 RNS
Total Voting Rights 02-Apr-2020 09:50 RNS
Holding(s) in Company 27-Mar-2020 15:37 RNS
Interim results for 6 months ended 31 Dec 2019 09-Mar-2020 07:00 RNS
Acquisition of Marker Gene Technologies 04-Mar-2020 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Abcam Market Data

Currency UK Pounds
Share Price 1,345.00p
Change Today -6.00p
% Change -0.44 %
52 Week High 1,530.00
52 Week Low 1,016.00
Volume 156,141
Shares Issued 216.17m
Market Cap £2,907.53m
RiskGrade 169

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.07% below the market average99.07% below the market average99.07% below the market average99.07% below the market average99.07% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
32.60% above the market average32.60% above the market average32.60% above the market average32.60% above the market average32.60% above the market average
15.79% below the sector average15.79% below the sector average15.79% below the sector average15.79% below the sector average15.79% below the sector average
Income
98.38% below the market average98.38% below the market average98.38% below the market average98.38% below the market average98.38% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Growth
7.44% above the market average7.44% above the market average7.44% above the market average7.44% above the market average7.44% above the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 3
Sell 0
Strong Sell 2
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 03-Jul-2020

Time Volume / Share Price
17:13 6,673 @ 1,348.04p
16:35 76,017 @ 1,345.00p
16:29 15 @ 1,343.00p
16:29 7 @ 1,343.00p
16:29 58 @ 1,343.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page